Published in J Infect Dis on December 01, 1992
The role of the acellular pertussis vaccine and the demise of 'Pertussis Pete'. Can J Infect Dis (2001) 0.75
The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med (2001) 7.49
Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child (1986) 7.39
Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev (1982) 4.03
Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr (1981) 4.00
Mortality and influenza. J Infect Dis (1982) 3.98
Interpandemic influenza in the Houston area, 1974-76. N Engl J Med (1978) 3.92
Mycoplasma pneumoniae disease: clinical spectrum, pathophysiology, epidemiology, and control. J Infect Dis (1971) 3.73
Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA (1999) 3.53
Patterns of shedding of myxoviruses and paramyxoviruses in children. J Infect Dis (1981) 3.30
Epidemiologic patterns of acute lower respiratory disease of children in a pediatric group practice. J Pediatr (1971) 2.75
Protection of infants from infection with influenza A virus by transplacentally acquired antibody. J Infect Dis (1980) 2.50
Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children. J Infect Dis (1984) 2.31
Occurrence of Diplococcus pneumoniae in the upper respiratory tract of children. J Pediatr (1975) 2.29
Respiratory disease in group day care. Pediatrics (1972) 2.01
Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses. Clin Infect Dis (1996) 1.98
Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981. Am Rev Respir Dis (1987) 1.84
Epidemiologic observations of influenza B virus infections in Houston, Texas, 1976-1977. Am J Epidemiol (1980) 1.74
The influenza herald wave. Am J Epidemiol (1982) 1.74
Influenza in children. Relationship to other respiratory agents. JAMA (1980) 1.73
Dual respiratory virus infections. Clin Infect Dis (1997) 1.67
Spectrum of clinical illness in hospitalized patients with "common cold" virus infections. Clin Infect Dis (2000) 1.66
Influenza: its control in persons and populations. J Infect Dis (1986) 1.65
Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. J Infect Dis (1993) 1.65
Live attenuated and inactivated influenza vaccine in school-age children. Am J Dis Child (1990) 1.56
Group A streptococci, mycoplasmas, and viruses associated with acute pharyngitis. JAMA (1967) 1.47
Maternal immunization against viral disease. Vaccine (1998) 1.47
Infection with influenza A/Victoria virus in Houston families, 1976. J Hyg (Lond) (1981) 1.44
Reinfection with influenza A (H3N2) virus in young children and their families. J Infect Dis (1979) 1.41
Influenza B virus infections in the community and the family. The epidemics of 1976-1977 and 1979-1980 in Houston, Texas. Am J Epidemiol (1983) 1.32
Acute respiratory disease associated with influenza epidemics in Houston, 1981-1983. J Infect Dis (1987) 1.30
Salmonella in two poultry processing plants. J Am Vet Med Assoc (1966) 1.27
Breast-feeding and respiratory virus infection. Pediatrics (1982) 1.25
A computerized reminder strategy is effective for annual influenza immunization of children with asthma or reactive airway disease. Pediatr Infect Dis J (2001) 1.24
Inactivated poliovirus vaccine: past and present experience. Vaccine (1996) 1.22
Antipyretic use among children during the 1983 influenza season. Am J Dis Child (1985) 1.22
Maternal immunization with pneumococcal polysaccharide vaccine in the third trimester of gestation. Vaccine (2001) 1.20
Considerations of the risk of influenza in children and indications for prophylaxis. Rev Infect Dis (1980) 1.20
Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses. J Infect Dis (1991) 1.16
Studies on the role of viruses, bacteria, and M. pneumoniae as causes of lower respiratory tract infections in children. J Pediatr (1968) 1.16
Acute respiratory disease hospitalizations as a measure of impact of epidemic influenza. Am J Epidemiol (1985) 1.14
Safety and immunogenicity of two inactivated poliovirus vaccines in combination with an acellular pertussis vaccine and diphtheria and tetanus toxoids in seventeen- to nineteen-month-old infants. J Pediatr (1997) 1.10
Fatal influenza B virus pneumonia in pediatric patients. Pediatr Infect Dis J (1992) 1.09
Acute respiratory disease of university students with special reference to the etiologic role of Herpesvirus hominis. Am J Epidemiol (1975) 1.07
Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four and six months of age. Pediatr Infect Dis J (1994) 1.07
An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults. Vaccine (2000) 1.05
Aspirin and Reye's syndrome. Am J Dis Child (1982) 1.05
Adverse reactions to the preschool (fifth) dose of adsorbed diphtheria-pertussis-tetanus vaccine in Canadian children. CMAJ (1991) 1.04
A field evaluation of inactivated, zonal-centrifuged influenza vaccines in children in Chapel Hill, North Carolina, 1968-69. Bull World Health Organ (1969) 1.02
Acquisition of serum antibodies to specific viral glycoproteins of parainfluenza virus 3 in children. J Virol (1984) 1.02
Transplacental antibody transfer following maternal immunization with polysaccharide and conjugate Haemophilus influenzae type b vaccines. J Infect Dis (1995) 1.02
Potentiation of the immune response to influenza virus subunit vaccines. J Immunol (1977) 1.02
Epidemic pyoderma caused by nephritogenic streptococci in college athletes. Lancet (1972) 1.00
Measles vaccination of infants in a well-vaccinated population. Pediatr Infect Dis J (1995) 0.97
Maternal immunization with Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in The Gambia. JAMA (1996) 0.95
Prevalence of neutralizing antibody to respiratory syncytial virus in sera from mothers and newborns residing in the Gambia and in The United States. Clin Diagn Lab Immunol (1996) 0.93
Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine. Vaccine (2012) 0.93
Booster effect of oral poliovaccine. Trials in persons previously immunized with inactivated vaccine. Am J Dis Child (1969) 0.93
Significance of mycoplasma infections in children with respiratory disease. Pediatrics (1967) 0.92
Swine-like influenza vaccine: a commentary. J Pediatr (1976) 0.92
A polysaccharide-protein complex from Haemophilus influenzae type b. III. Vaccine trial in human adults. J Infect Dis (1981) 0.91
Quantitative relationship of preexisting homotypic antibodies to excretion of poliovirus types 1, 2, and 3 following the feeding of trivalent attenuated poliovirus vaccine. Am J Epidemiol (1969) 0.90
Influenza and hospitalizations in children. N Engl J Med (2000) 0.89
Antigenicity and reactogenicity of influenza A/USSR/77 virus vaccine in children--a multicentered evaluation of dosage and safety. Rev Infect Dis (1983) 0.89
HLA-restricted CD8+ cytotoxic T lymphocyte, interferon-gamma, and interleukin-4 responses to respiratory syncytial virus infection in infants and children. J Infect Dis (2001) 0.87
Haemophilus influenzae type b-specific antibody in infants after maternal immunization. Pediatr Infect Dis J (1997) 0.87
Trivalent, inactivated influenza virus vaccine in children with sickle cell disease. Am J Dis Child (1983) 0.86
Passive protection against respiratory syncytial virus disease in infants: the role of maternal antibody. Pediatr Infect Dis J (1994) 0.86
Immunogenicity of influenza A/USSR (H1N1) subunit vaccine in unprimed young adults. J Med Virol (1981) 0.85
Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults. Pediatr Infect Dis J (2000) 0.85
Reactogenicity and immunogenicity of bivalent influenza A and monovalent influenza B virus vaccines in high-risk children. J Infect Dis (1977) 0.84
Quantitative relationship of preexisting homotypic antibodies to the excretion of attenuated poliovirus type 1. Am J Epidemiol (1966) 0.84
Safety and antibody persistence following Haemophilus influenzae type b conjugate or pneumococcal polysaccharide vaccines given before pregnancy in women of childbearing age and their infants. Pediatr Infect Dis J (2001) 0.84
Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid? CMAJ (1993) 0.83
First International Symposium on Influenza and Other Respiratory Viruses: summary and overview: Kapalua, Maui, Hawaii, December 4-6, 1998. Antiviral Res (1999) 0.83
Surveillance of influenza in Houston, Texas, USA: gradual transition from A/Victoria/75 (H3N2) to A/Texas/77 (H3N2) predominance and antigenic characterization of "intermediate" strains. Bull World Health Organ (1983) 0.83
Evaluation of booster doses of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in 18-month-old children. Vaccine (1995) 0.83
Serological evidence of Hantaan virus infection in the United States. Am J Trop Med Hyg (1985) 0.83
Effect of passive antibody on parainfluenza virus type 3 pneumonia in hamsters. Infect Immun (1976) 0.82
Maternal immunization with Haemophilus influenzae type b vaccines in different populations. Vaccine (2003) 0.82
Effectiveness of rimantadine prophylaxis of children within families. Am J Dis Child (1986) 0.82
Alternative approaches to immunization of children with inactivated influenza virus vaccines. J Infect Dis (1977) 0.82
Clinical and radiographic assessment of acute lower respiratory tract disease in infants and children. Semin Respir Infect (1987) 0.82
Patterns of virus infections in families with acute respiratory illnesses. Am J Epidemiol (1967) 0.81
Cell-mediated and antibody immune responses to AIK-C and Connaught monovalent measles vaccine given to 6 month old infants. Vaccine (1999) 0.81
Herpesvirus hominis encephalitis. Virus isolation from brain biopsy in seven patients and results of therapy. Arch Neurol (1973) 0.81
Reactive airway disorders in children. Role of respiratory virus infections. Clin Chest Med (1984) 0.81
Antigenic analysis of H1N1 viruses isolated in the Houston metropolitan area during four successive seasons. Infect Immun (1983) 0.81
Humoral and cellular immune responses to an inactivated Mycoplasma pneumoniae vaccine in children. J Infect Dis (1973) 0.81
Studies on the humoral immune response to a synthetic vaccine against Plasmodium falciparum malaria. Clin Exp Immunol (1991) 0.81
Influenza C virus infection. Arch Intern Med (1980) 0.80
Epidemiology and molecular characterization of co-circulating influenza A/H3N2 virus variants in children: Houston, Texas, 1997-8. Epidemiol Infect (2003) 0.80
Post-marketing surveillance of adverse events following ProHIBit vaccine--British Columbia. Can Dis Wkly Rep (1989) 0.80
Comparison of a fifth dose of a five-component acellular or a whole cell pertussis vaccine in children four to six years of age. Pediatr Infect Dis J (1999) 0.80
Adverse reactions and antibody response to four doses of acellular or whole cell pertussis vaccine combined with diphtheria and tetanus toxoids in the first 19 months of life. Vaccine (1996) 0.79